HER 2 Positive Gastric Cancer
5 clinical trials · Condition
◉ Watch HER 2 Positive Gastric Cancer
| Record | Firm | Date |
|---|---|---|
| Herzuma-capecitabine/Cisplatin for Gastric Cancer (NCT03588533) | Sung Yong Oh | 2018-06-10 |
| Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment (NCT02274012) | Columbia University | 2014-05-29 |
| Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver Metastasis (NCT02380131) | Hebei Medical University | 2013-02-01 |
| Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC): Her+XELOX (NCT01396707) | Asan Medical Center | 2011-06-01 |
Track HER 2 Positive Gastric Cancer automatically
Every clearance here is in the API, with alerts when new ones post.